BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 9 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $27,560,000 | +25.2% | 6,176,000 | 0.0% | 0.02% | +31.6% |
| Q3 2014 | $22,017,000 | +16.0% | 6,176,000 | +0.0% | 0.02% | +5.6% |
| Q2 2014 | $18,977,000 | -10.2% | 6,175,000 | -1.6% | 0.02% | -18.2% |
| Q1 2014 | $21,124,000 | -3.0% | 6,274,000 | +0.2% | 0.02% | +10.0% |
| Q4 2013 | $21,776,000 | +837.0% | 6,262,000 | +867.9% | 0.02% | +900.0% |
| Q3 2013 | $2,324,000 | +14.9% | 647,000 | -10.5% | 0.00% | 0.0% |
| Q2 2013 | $2,023,000 | – | 723,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Amici Capital, LLC | 8,000,000 | $35,720,000 | 1.61% |
| Baker Brothers Advisors | 22,898,000 | $102,104,000 | 1.04% |
| CITIGROUP INC | 6,176,000 | $27,560,000 | 0.02% |
| SG Americas Securities, LLC | 10,000 | $4,465,000 | 0.02% |
| SSI INVESTMENT MANAGEMENT LLC | 37,000 | $165,000 | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 1,000,000 | $4,462,000 | 0.00% |
| Allianz Asset Management GmbH | 300,000 | $1,340,000 | 0.00% |
| UBS Group AG | 22,000 | $98,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,000 | $8,000 | 0.00% |
| MORGAN STANLEY | 11,000 | $49,000 | 0.00% |